Can I-123-FP-CIT images give us a clue that implies a vascular parkinsonism?

Clinical Nuclear Medicine

Volumn 32, Issue 11, 2007, Pages 886-888

  Mila M ^a   Cuberas, G ^a   Rovira, A ^a   Porta, F ^a   Negre, M ^a   Rossi, S ^a   Miquel, F ^a   Castell Conesa, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

123I Ioflupane SPECT; Perfusion brain imaging; Vascular parkinsonism

Indexed keywords

IOFLUPANE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN PERFUSION; CASE REPORT; CAUDATE NUCLEUS; COMPUTER ASSISTED TOMOGRAPHY; CORPUS STRIATUM; DRUG UPTAKE; HUMAN; MALE; NEUROIMAGING; PARKINSONISM; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CEREBRAL INFARCTION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; PUTAMEN; TROPANES;

EID: 37349096957     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318156bbb9     Document Type: Article

References (8)

1. Zijlmans J, Daniel S, Hughes AJ, et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004;19:630-640.
2. Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord. 2003;18:1415-1423.
3. Inzelberg R, Bornstein NM, Reider I, et al. Basal ganglia lacunes and parkinsonism. Neuroepidemiology. 1994;13:108-112.
4. Tolosa ES, Santamaria J. Parkinsonism and basal ganglia infarcts. Neurology. 1984;34:1516-1518.
5. Gerschlager W, Bencsits G, Pirker W, et al. (123I)Beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov Disord. 2002;17:518-523.
6. 123I-FP-CIT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med. 2004;45:1688-1693.
7. 99mTc-TRODAT-1. J Nucl Med. 2001;42:408-413.
8. Zijlmans JCM, Katzenschlager R, Daniel SE, et al. The L-Dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry. 2004;75:545-547.